Breaking News

Synteract CRO To Open Prague Office

Synteract will open a Central Eastern European office in Prague, Czech Republic, this summer.

Synteract will open a Central Eastern European office in Prague, Czech Republic, this summer. The office will offer regulatory, site management/monitoring, pharmacovigilence and project management services, including data management, biostats (including CDISC) and medical writing are available to clients globally.

The separate business unit will be headed by Kristi Clark, currently the senior director of Project Management and Global Business Operations at the headquarters office in Carlsbad, CA. Ms. Clark has been with the company for almost four years and has more than 19 years of industry experience, which includes 12 years of global trial experience in the biopharma industry.

Chief executive officer Ellen Morgan said, “Our goal is to provide our clients with the same flexibility, guidance and responsive service for their multinational trials that they have become accustomed to when working with us domestically. We decided that this year is the right time to move forward to provide the one-stop shop and broader services they need. Having Kristi on the ground in Europe will also help us to evaluate additional potential partners who fit our model.”

“We will maintain the same level of service in our Central Eastern European office that we now offer in our U.S.-based offices, yet still retain our corporate culture overseas,” said Ms. Clark. “Having key Synteract employees transferred from the U.S. to the Prague office confirms our commitment to quality and will help our clients have more confidence that their international trials will meet the standards they expect from our company, to support them with continuity from phase one to four trials.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters